US telehealth peersAMWL stock is up almost 100% in the last month, bouncing back from its 52 week low. TDOC is also showing some relative strength.
a note for LarryBird - AMWL trades at 5X-6X sales, loses money on a GAAP basis, and is EBITDA / cashflow negative. a bit of a different scale than Circle (WELL's telehealth sub) with Revenues > $250MM and the fact they're sitting on a pile of cash from a Google investment. it's also pure play telehealth. in any event, thought I would bring this to your attention since you seemed skeptical about comparables garnering a 5X Rev valuation.
as an aside I would note that US institutional investors are usually far more comfortable paying for growth. I don't think a NASDAQ listing is in the cards for WELL, it's too bad they missed their window of opportunity on that.